🇺🇸 FDA
Patent

US 10450306

Isoxazole analogs as FXR agonists and methods of use thereof

granted A61PA61P1/16A61P13/12

Quick answer

US patent 10450306 (Isoxazole analogs as FXR agonists and methods of use thereof) held by Enanta Pharmaceuticals, Inc. expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enanta Pharmaceuticals, Inc.
Grant date
Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P1/16, A61P13/12, A61P3/00, A61P9/00